Work

MA25.04 Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Outcomes After Pembrolizumab Based First Line Therapy in Metastatic NSCLC

Year: 2019

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.712

Authors: C. Aggarwal, J. Thompson, A. Chien, K. Quinn, M. Lefterova, R. Nagy, S. Yee, M. Lariviere, C. Ciunci, A. Singh, J. Bauml, R. Cohen, C. Langer, E. Carpenter

Institutions: Abramson Cancer Center, University of Pennsylvania, Guardant (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2981761989

Cites:

Cited by: 5

Related to: 10